Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Follow-up Study of EVA-001 for Knee Osteoarthritis
jRCT2033260212Recruiting
- Sponsor
- MEDIPOST
- Start
- Jun 2026
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of EVA-001 in knee osteoarthritis (OA), sponsored by MEDIPOST. Primary endpoint: Change from baseline in the WOMAC Scale at 60 months post-administration. Started Jun 2026; status: recruiting.
02
Drugs
EVA-001
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on jRCT2033260212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2033260212.